Mantis Biotech is building digital copies of human bodies to help doctors and researchers study diseases without needing real patient data. These “digital twins” combine different types of medical information to create virtual versions of how our bodies work.
This could solve a huge problem in medical research. Doctors often can’t get enough patient data to study rare diseases or test new treatments. Privacy laws make it even harder to share medical information between hospitals and research centers.
Virtual Patients That Act Like Real Ones
Mantis combines data from medical scans, lab tests, and patient records to build these digital humans. The virtual bodies can show how diseases progress, how organs interact, and how different treatments might work. It’s like having a computer simulation of a person that doctors can study and experiment on safely.
The synthetic datasets don’t contain any real patient information, which solves privacy concerns. Researchers can run thousands of virtual tests without putting anyone at risk or waiting years for clinical trials.
What This Could Change
If successful, digital twins could speed up drug discovery and help doctors understand rare diseases better. Pharmaceutical companies could test medications on virtual patients before moving to human trials. Doctors might even create digital copies of their own patients to predict how they’ll respond to different treatments.
Mantis isn’t the only company working on this idea, but they’re focusing specifically on solving medicine’s data shortage problem through synthetic information that mimics real human biology.